DK1105099T3 - Sammensætning af fiskegelatine til brug som ingrediens i tabletter - Google Patents

Sammensætning af fiskegelatine til brug som ingrediens i tabletter

Info

Publication number
DK1105099T3
DK1105099T3 DK99936451T DK99936451T DK1105099T3 DK 1105099 T3 DK1105099 T3 DK 1105099T3 DK 99936451 T DK99936451 T DK 99936451T DK 99936451 T DK99936451 T DK 99936451T DK 1105099 T3 DK1105099 T3 DK 1105099T3
Authority
DK
Denmark
Prior art keywords
composition
fish
tablets
ingredient
fish gelatin
Prior art date
Application number
DK99936451T
Other languages
English (en)
Inventor
Hansen Morten Mohr
Per Vilstrup
Jensen Nina Musaeus
Original Assignee
Basf Health & Nutrition As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Health & Nutrition As filed Critical Basf Health & Nutrition As
Application granted granted Critical
Publication of DK1105099T3 publication Critical patent/DK1105099T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99936451T 1998-08-25 1999-08-23 Sammensætning af fiskegelatine til brug som ingrediens i tabletter DK1105099T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801065 1998-08-25
PCT/DK1999/000446 WO2000010525A2 (en) 1998-08-25 1999-08-23 Fish gelatinous composition for use as an ingredient in tablets

Publications (1)

Publication Number Publication Date
DK1105099T3 true DK1105099T3 (da) 2003-07-14

Family

ID=8100602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936451T DK1105099T3 (da) 1998-08-25 1999-08-23 Sammensætning af fiskegelatine til brug som ingrediens i tabletter

Country Status (11)

Country Link
EP (1) EP1105099B1 (da)
JP (1) JP2002523350A (da)
CN (1) CN1150892C (da)
AT (1) ATE237313T1 (da)
AU (1) AU745294B2 (da)
CA (1) CA2341976C (da)
DE (1) DE69906989T2 (da)
DK (1) DK1105099T3 (da)
ES (1) ES2192064T3 (da)
NZ (1) NZ510360A (da)
WO (1) WO2000010525A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
DE60200861T2 (de) * 2001-07-02 2005-08-04 Bioprogress S.P.A. Verwendungen einer Zusammensetzung enthaltend teilweise hydrolysiertes Fischgelatin
WO2006123173A1 (en) * 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
ATE510615T1 (de) * 2006-04-04 2011-06-15 Firmenich & Cie Verfahren zur herstellung von mikrokapseln mittels koazervatbildung
KR102653069B1 (ko) * 2015-02-06 2024-03-29 바스프 에스이 루테인 또는 루테인 에스테르를 포함하는 마이크로캡슐
BR112018011476B1 (pt) * 2015-12-10 2022-04-12 Dsm Ip Assets B.V. Tabletes comprimidos compreendendo pelo menos uma partícula sólida de vitamina e seu uso
WO2019091735A1 (en) 2017-11-13 2019-05-16 Unilever N.V. Food concentrate and process for preparing the concentrate
CN109248151B (zh) * 2018-10-25 2020-11-06 广州市炜鑫生物科技有限公司 一种用于片剂制剂的鱼明胶组合物及其制备方法
CN113260351A (zh) * 2018-12-29 2021-08-13 3M创新有限公司 口腔制品及使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892889A (en) * 1986-11-18 1990-01-09 Basf Corporation Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin
JPS63145659A (ja) * 1986-12-09 1988-06-17 ライオン株式会社 ゲル状芳香剤の製造方法
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
JPH06254382A (ja) * 1993-03-05 1994-09-13 Riken Vitamin Co Ltd マイクロカプセルの製造法およびその製造装置
US5603952A (en) * 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom

Also Published As

Publication number Publication date
CN1313759A (zh) 2001-09-19
EP1105099A2 (en) 2001-06-13
CN1150892C (zh) 2004-05-26
DE69906989D1 (de) 2003-05-22
CA2341976A1 (en) 2000-03-02
DE69906989T2 (de) 2003-11-06
WO2000010525A2 (en) 2000-03-02
AU5154599A (en) 2000-03-14
AU745294B2 (en) 2002-03-21
EP1105099B1 (en) 2003-04-16
JP2002523350A (ja) 2002-07-30
ATE237313T1 (de) 2003-05-15
ES2192064T3 (es) 2003-09-16
WO2000010525A3 (en) 2000-06-02
NZ510360A (en) 2003-04-29
CA2341976C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
ATE143830T1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
ATE64849T1 (de) Formulierung mit langsamer freisetzung.
DK0858328T3 (da) Stabile præparater indeholdende N-propargyl-1-aminoindan
ATE113832T1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
HRP20010243B1 (hr) Pripravci koji sadrže difosfonske kiseline
DK0642344T3 (da) Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering.
DE59806776D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
DE50112438D1 (de) Zahnpflegemittel in portionskapseln
NZ510360A (en) Fish gelatinous composition for use as an ingredient in tablets
RU94008619A (ru) Производные дигидробензофурана, гербицидная композиция и способ уничтожения сорняков
TR199802670T2 (xx) Pestisidal tablet form�lasyonlar�.
TR199801126T2 (xx) Tolfenamik asit veya bunun farmas�tik a��dan kabul edilebilir bir tuzunu i�eren h�zl� tahliye edici tablet.
AR000555A1 (es) Uso de composiciones anabolicas para la masa osea en base a cantidades efectivas no toxicas del ácido Ä3-(n,n-dimetilamino)-1-hidroxipropilidenoÜbisfosfonico o la sal monosodica u otra sal farmacéuticamente aceptable del mismo
FR2678144B1 (fr) Compositions sous forme de pellets contenant des principes actifs degradables par la chaleur et la pression.
BR9603430A (pt) Composições pesticidas
DK0804152T3 (da) Lactulose-pastiller
MX9303588A (es) Herbicidas novedosos.
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
MA23183A1 (fr) Compositions pour la preservation de vegetaux
ITMI951210A0 (it) Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi
ITMI911653A1 (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.